Tag Archives: Rite Aid

Specialty Pharmacy News Roundup: October 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Elixir Launches a Specialty Generic Program

Elixir, a wholly owned subsidiary of Rite Aid, recently announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022

Rite Aid’s Disappointing PBM Q3 2021 Results Leads to Rebate Aggregation Agreement with Prime Therapeutics

Rite Aid is implementing a number of strategies to make up Q3 2021 PBM revenue shortfall, including closing 63 stores and improving PBM margins from its new rebate aggregation agreement with Prime Therapeutics

Rite Aid’s Elixir Q2 2022 Revenues Decreased 6.9% Driving the Company’s Net Loss

Rite Aid’s net loss from continuing operations was $100.3 million compared to last year’s second quarter net loss from continuing operations of $13.2 million